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Entamoeba histolytica (Eh) is a protozoan parasite that infects 10% of the world’s
population and results in 100,000 deaths/year from amebic dysentery and/or liver
abscess. In most cases, this extracellular parasite colonizes the colon by high affinity
binding to MUC2 mucin without disease symptoms, whereas in some cases, Eh triggers
an aggressive inflammatory response upon invasion of the colonic mucosa. The specific
host-parasite factors critical for disease pathogenesis are still not well characterized.
From the parasite, the signature events that lead to disease progression are cysteine
protease cleavage of the C-terminus of MUC2 that dissolves the mucus layer followed
by Eh binding and cytotoxicity of the mucosal epithelium. The host mounts an ineffective
excessive host pro-inflammatory response following contact with host cells that causes
tissue damage and participates in disease pathogenesis as Eh escapes host immune
clearance by mechanisms that are not completely understood. Ameba can modulate
or destroy effector immune cells by inducing neutrophil apoptosis and suppressing
respiratory burst or nitric oxide (NO) production from macrophages. Eh adherence to
the host cells also induce multiple cytotoxic effects that can promote cell death through
phagocytosis, apoptosis or by trogocytosis (ingestion of living cells) that might play critical
roles in immune evasion. This review focuses on the immune evasion mechanisms that
Eh uses to survive and induce disease manifestation in the host.
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INTRODUCTION
Entamoeba histolytica (Eh), the causative agent of amebiasis, is an intestinal protozoan parasite that
colonizes the intestinal lumen asymptomatically (known as noninvasive disease) in approximately
90% of cases. However, in 10% of individuals, this asymptomatic relationship breaks down and the
parasite breaches the innate mucosal barrier and invades the underlying lamina propria resulting
in 100,000 death per year globally (Stanley, 2003). Parasite cysts are acquired through the ingestion
of contaminated food and water mostly in areas of poor sanitation (Ralston and Petri, 2011a).
Birth cohort studies done in an urban slum in Dhaka, Bangladesh found that approximately 50%
of infants are infected in the first year of life, with repeated infections that are connected with
malnourishment and stunting (Mondal et al., 2006; Korpe et al., 2013). The exact reasons why Eh
occasionally invade the mucosal epithelium and what host-parasite factors are involved in parasite
invasion are not clear. The outcome of invasive Eh infection is variable; it can result in amebic
diarrhea, amebic colitis, and/or dissemination of the parasites through the portal circulation to
cause liver abscess (Ralston and Petri, 2011b). Eh invasion induces a robust pro-inflammatory
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response and host tissue destruction that exacerbates disease
(Moonah et al., 2013; Mortimer et al., 2015). Currently, there
is no effective vaccine for this disease; however nitroimidazoles
(such as metronidazole) are effective to treat this tissue dwelling
parasites. Metronidazole treatment can cause toxic side effects
and enhance the probability of developing drug resistant (Petri,
2003; Ralston and Petri, 2011b). Our host immune system sets
up a series of defensive responses against the parasite. However,
continued morbidity and mortality point out that this parasite is
capable of escaping host defense responses to maintain its own
survival (Moonah et al., 2013). Thus, an understanding of the
human immune response to the parasite and the strategies used
by the parasite to evade host defense will deeply improve the
development of effective immunotherapies. In this review, wewill
focus on the host immune responses against Eh and the complex
strategies the parasite uses to evade host immunity.
HOST IMMUNITY AGAINST E. histolytica
Innate and Adaptive Immune Response
For any ingested parasite, immunity begins from the stomach
acid as it has the ability to kill acid-sensitive microorganisms.
However, the mucus barrier of the intestine serves as the first
protective layer that prevents Eh from making contact with the
underlying intestinal epithelial cells (IECs; Moonah et al., 2013).
There are three major virulent factors of Eh known to mediate
pathogenicity: (1) galactose/N-acetylgalactosamine-inhibitable
lectin (Gal-lectin) is responsible for binding colonic mucin in
colonization and host cell adhesion in disease pathogenesis, (2)
pore forming peptide amoebapore used for host cell killing
and, (3) cysteine proteases that lyse host extracellular matrix
(Campos-Rodríguezp and Jarillo-Luna, 2005) and stimulate pro-
inflammatory responses. The mucus barrier in the colon is
composed of MUC2 mucin, which is a glycoprotein secreted
from goblet cells. Mucin binds with high affinity to Eh Gal-lectin
allowing the parasite to colonize the gut and at the same time
it acts as a physical barrier to inhibit parasite invasion of the
underlying epithelium (Chadee et al., 1987; Moonah et al., 2013).
When Eh overcomes innate host defenses and contact IECs they
produce a variety of pro-inflammatory mediators/chemokines
including interleukin-1 (IL-1β), interleukin-8 (IL-8), and TNF-
α. Several of these mediators trigger the recruitment of immune
cells including neutrophils and macrophages to the site of
parasite invasion (Yu and Chadee, 1997). The main amebicidal
activity of neutrophils is the release of reactive oxygen species
(ROS; Guerrant et al., 1981; Denis and Chadee, 1989). In
macrophages Eh Gal-lectin up-regulates the mRNA expression
of different cytokines. Gal-lectin induces pattern recognition
receptor (PRRs) such as TLR-2 and TLR-4 mRNA expression in
macrophages which is controlled by nuclear factor NF-κB and
MAPK pathway. Recognition of parasite molecules by surface
PRRs are crucial for the up-regulation of pro-inflammatory
cytokine expression via NF-κB (Kammanadiminti et al., 2004).
Macrophages activated with cytokines such as IFN-γ or TNF-
α kills Eh trophozoites in vitro by producing nitric oxide (NO)
from L-arginine mediated by inducible nitric oxide synthase
(iNOS) (Lin et al., 1994). NO is critical for macrophage-mediated
killing as iNOS deficient mice are more vulnerable to amebic liver
abscess (ALA) and hepatocytic apoptosis (Seydel et al., 2000).
Interferon gamma (IFN-γ) is the major cytokine that activates
neutrophils andmacrophages to exert amebicidal activity. Higher
levels of IFN-γ are related to a lower incidence of Eh infection
(Denis and Chadee, 1989; Ghadirian and Denis, 1992; Haque
et al., 2007).
Humoral immune responses against Eh are well characterized
and it was been found that 81–100% of invasive amebiasis
patients develop circulatory antibodies within 7 days of infection
(Kaur et al., 2004). A prospective cohort study of pre-school
children in Dhaka, Bangladesh, showed that mucosal IgA
antibodies against the carbohydrate recognition domain (CRD)
of the Gal-lectin heavy chain provided protection against Eh
infection and disease (Haque et al., 2001, 2006). In contrast,
serum anti-lectin IgG was not associated with protection but
mainly with the frequency of new infection (Haque et al.,
2001). Higher levels of anti-lectin IgG was found in ALA
and intestinal amebiasis as compared to asymptomatic patients
(Kaur et al., 2004). These findings indicate that systematic anti-
lectin antibodies are not involved in direct protection against
amebiasis.
Inflammasome Activation by E. histolytica
Eh imposes damage through the adherence to host cells, which
plays a critical role in killing or ingesting host target (Mortimer
and Chadee, 2010). Thus, amebae adherence to host cell is one
of the major characteristics of Eh pathogenicity. At present, the
pattern recognition receptors (PRRs) that bind Eh Gal-lectin
are not known. We recently identified that the inflammasome
pathway is only activated on contact with live Eh and
distinguishes between different physical forms of Eh (Mortimer
et al., 2014). Inflammasome is a cytosolic multiprotein complex,
which acts as a sensor for pathogens and cellular damage.
This multimeric complex consists of an inflammasome sensor
molecule (NOD-like receptor), the adaptor protein ASC and
caspase-1. Activation of inflammasome leads to rapid and robust
secretion of IL-1β, IL-18, IL-1α, FGF-2, IP-10 (Mortimer et al.,
2014). Interestingly, when Eh activates the inflammasome, it does
not trigger caspase-1 dependent cell death (known as pyroptosis)
(Mortimer et al., 2014). It is unclear if inflammasome-activated
macrophages are amebicidal and whether it plays other protective
roles in amebic infection. On the other hand, if inflammasome
activation triggers cell death in macrophages (pyroptotic cell
death), Eh can use it as an advantage to limit immune elimination
that can become detrimental to host defense.
IMMUNE EVASION MECHANISMS OF
E. histolytica
Eh has a two-phase life cycle: it can survive as an infective
cyst in the environment or it can be found as trophozoites, the
feeding and tissue dwelling stage in the human colon. After
excystation in the colon, Eh trophozoites usually establishes
harmless colonization where the parasites reside in the gut lumen
and feed on enteric bacteria by phagocytosis (Voigt et al., 1999;
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Wilson et al., 2012). However, for unknown reasons trophozoites
can become invasive, where parasite virulence factors allow it
to degrade colonic mucin and other innate epithelial barrier
functions (Wilson et al., 2012). Host immune responses, both
innate and adaptive, are robust against invasive Eh but still
this parasite is able to survive by developing immune evasion
strategies. In particular, Eh cysteine proteases can cleave MUC2
mucin abrogating its protective functions allowing the parasite to
breach the mucus layer and attach to the underlying epithelial
cells (Lidell et al., 2006). Intestinal antimicrobial peptides are
also an important component of host innate immune defense.
Even though human LL-37 and murine CRAMP (cathelin-
related antimicrobial peptide) cathelicidins are induced by Eh
trophozoites both at the mRNA and protein level in IECs, Eh
cysteine proteases can cleave these antimicrobial peptides (Cobo
et al., 2012). Thus, Eh is resistant to both intact and cleaved
antimicrobial cathelicidins in the intestine (Cobo et al., 2012).
After amebic invasion, neutrophils are the earliest infiltrating
cells but virulent Eh are effective in killing, lysing, and
phagocytosing neutrophils. In vitro, one trophozoite was
shown to kill approximately 3000 neutrophils (Guerrant
et al., 1981; Guo et al., 2007). There are several conflicting
mechanisms by which ameba interfere with neutrophil functions.
Eh can disrupt NADPH oxidase activities and inhibit the
respiratory burst of neutrophils to avoid oxidative stress.
Eh iron-containing superoxide dismutase and NADPH:flavin
oxidoreductase (Elnekave et al., 2003) are able to detoxify ROS
by forming H2O2 (Bruchhaus et al., 1998; Sim et al., 2005). Eh
trophozoites can protect themselves from neutrophil reactive
oxygen properties with a 29-kDa surface protein, peroxiredoxin
that has potent antioxidant activity (Davis et al., 2006). Studies
have shown (Sim et al., 2005) that Eh can induce host cells
(neutrophil) apoptosis through the activation of ERK1/2 by the
generation of NADPH oxidase-derived ROS.
Macrophages, another effector cell present during amebic
infection also show suppressed cell mediated immunity due
to Eh-induced strategic immune modulation. Eh trophozoites
inhibit respiratory burst (ROS: H2O2, O
2−, OH−) and NO
production by macrophages (Lin et al., 1993; Wang et al.,
1994). NOS substrate L-arginine is competitively converted
to L-ornithine by ameba arginase that limit NO production
by macrophages (Elnekave et al., 2003). When Eh and
macrophages are exposed to each other, ameba produces
the immunoregulatory molecule prostaglandin E2 (PGE2),
synthesized by a cyclooxygenase (COX)-like enzyme by the
parasite (Dey et al., 2003). Coupling through EP2/4 receptors,
PGE2 increases cyclic adenosine monophosphate (cAMP)
levels in macrophages that inhibits Th1 cytokine release,
NADPH-mediated oxidative burst, and NO synthesis through
the protein kinase C (PKC) pathway (Wang and Chadee,
1995). Another immunosuppressive pentapeptide, monocyte
locomotion inhibitory factor (MLIF) produced by Eh showed
anti-inflammatory activities by inhibiting NO production (Rico
et al., 2003).
The complement system of the host is able to prevent
trophozoite dissemination into the extra intestinal space.
Activated complement forms the membrane attack complex
(MAC) that can potentially lyse the parasite. Eh resists
complement activation by the Gal-lectin which have sequence
resemblance and antigenic cross reactivity with the MAC-
inhibitory protein CD59 and thus inhibit MAC-mediated
lysis (Braga et al., 1992). Cysteine proteases can also cleave
complement components (Reed et al., 1995). The potent pro-
inflammatory activities of the complement component C3a
and C5a are degraded by Eh secreted extracellular cysteine
proteases (Zambrano-Villa et al., 2002). Secretory IgA and serum
IgG mediate adaptive immunity against Eh and ameba can
degrade these immunoglobulins in vitro. Eh extracellular cysteine
proteases play a key role in the disruption of host adaptive
defenses. For successful invasion, Eh secreted and membrane-
bound cysteine proteases cleave extracellular matrix proteins,
fibronectin, and laminin and avoid host defenses by cleaving
gut lumen sIgA and circulatory IgG (Que and Reed, 1997;
Zambrano-Villa et al., 2002).
E. histolytica-induced Cell Death: Immune
Evasion Strategy
Eh uses different strategies to evade host immune defense but
one striking mechanism is the induction of host cell death. The
term “histolytica” refers to Eh ability to destroy host tissues by
potent cytotoxicity/cell killing activity toward different host cells
including neutrophils, macrophages, T-lymphocytes; though the
exact mechanism of host cell killing is not clear. Eh has several
cytotoxic effector molecules (Table 1) but how ameba deliver this
deadly action is not clear. Eh can induce host cell apoptosis,
phagocytosis and amebic trogocytosis; the latter involving a
recently described mechanism of ameba-induced host cell killing
(Ralston et al., 2014).
Apoptotic Cell Death
Host cell killing is usually a stepwise process mediated by parasite
adherence to the target cell, elevation of intracellular calcium
level, dephosphorylation of host proteins which all contribute to
cell death via activation of caspase-3 (Ralston and Petri, 2011b).
Caspase-3 activation is the signature event of apoptosis. The first
step of adherence is mediated by the parasite surface Gal-lectin
to host cell carbohydrate determinants containing Gal and/or
GalNAc residues (Figure 1A). Gal-lectin mediated adherence to
target cell is a prerequisite for parasite cytotoxicity as the addition
of excess Gal or GalNAc monomers inhibit Eh adherence and
target cell killing (Ravdin and Guerrant, 1981; Saffer and Petri,
1991). Adherence to the target cell induces calcium flux which
also contribute to the cell killing proved by the inhibition
of calcium channel or by using calcium chelators (Ravdin
et al., 1982; Ralston and Petri, 2011b). Amebic cytotoxicity
both in vitro and in vivo occurs via the caspase-3 dependent
apoptotic cell death pathway in Jurkat cells after contact with
Eh (Figures 1A,C) (Seydel and Stanley, 1998; Ralston and Petri,
2011b). Caspase-3 knockout mice are resistant to amebiasis and
a pharmacological inhibitor of caspase-3, Ac-DEVD-CHO (N-
acetyl-Asp-Glu-Val-Asp-aldehyde) reduces parasite cytotoxicity
to host cells (Huston et al., 2000; Becker et al., 2010). Studies
illustrate that Eh-induced apoptosis is independent of caspase-
8 or caspase-9 (Huston et al., 2000). Another study showed that
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TABLE 1 | Potential cytotoxic effector molecules identified in Entamoeba histolytica.
Eh effectors molecules Identified effect on host cell References
Amebapores Pore forming proteins Leippe et al., 1991
All three types induce pore formation in synthetic liposomes Andrä et al., 2003
Amebapore A Active at low pH 5.2. May play a role in host cell killing before ingestion Andrä et al., 2003
Amebapore B
Amebapore C
In vitro, purified amebapores showed bactericidal activity against Gram-positive
bacteria at nanomolar concentration
Purified amebapores are cytotoxic to Jurkat or U937 cells at micromolar
concentration
Leippe et al., 1994; Andrä et al., 2003
Cysteine proteinases (CPs) At least 50 CP genes are encoded and some of them are secretory Tillack et al., 2007
Proteinases act on a variety of host substrates such as mucin, villin, laminin, collagen,
proteoglycan, and extracellular matrix (ECM). It plays a role in pathogenesis by
cleaving MUC mucin and ECM degradation
Li et al., 1995; Lidell et al., 2006
In vivo, overexpression of EhCP5 (EhCP5) increases liver abscess formation
compared to wild-type controls. Other CPs like EhCP1 or EhCP2 overexpression had
no effect
Hellberg et al., 2001; Tillack et al.,
2006
Membrane proteins: Gal/GalNAc
lectin associated
35kDa light subunit of the Gal/GalNAc lectin and surface-localized thiol-dependent
peroxidase
Ankri et al., 1999; Sen et al., 2007
Antisense inhibition of both of these prevents cell killing and deceased liver abscess Ankri et al., 1999; Sen et al., 2007
EhSTIRPs (Eh serine, threonine and
isoleucine rice proteins)
Silenced by dsRNA resulted in defects in both adhesion and cytotoxicity MacFarlane and Singh, 2007
EhTMKB1-9 (Eh transmembrane
kinase B1-9)
Antisense inhibition of this protein showed defects in both adhesion and host cell
killing
Shrimal et al., 2010
KERP1 (Lysine and glutamic acid rice
protein 1)
Parasite membrane protein binds to host cell membrane Santi-Rocca et al., 2008
Antisense inhibition of this protein failed to decrease mRNA but due to affinity for host
cell membranes, it might have role in cytotoxicity
Eh killing of hepatocyte and immune cell was not dependent
or mediated by the classical Fas/Fas ligand or TNFα receptor
pathway (Seydel and Stanley, 1998). Mice lacking Fas or
producing a mutated non-functional Fas protein developed
amebic ALA similar to wild type mice. Similarly, TNF receptor
knockout mice and wild type mice develop comparable ALA
(Seydel and Stanley, 1998). Eh induces a non-classical pathway
of apoptosis that may have an important role in pathogenesis
(Seydel and Stanley, 1998; Huston et al., 2000). Apoptotic cell
death is immunologically silent, thus induction of host cell
apoptosis by Eh tricks the host cell to kill itself without evoking an
inflammatory response to avoid being detected by other immune
cells. The importance of apoptosis in regards to amebic virulence
is brought to light by studies of the leptin-signaling pathway.
The hormone leptin is linked to malnutrition (signals satiety)
and regulates the immune response to infection through the
Th1 inflammatory response and by preventing apoptosis (Wilson
et al., 2012). Leptin signaling provides protection from mucosal
destruction and experiments in mice showed the anti-apoptotic
role of leptin in gut epithelia (Guo et al., 2011). Polymorphism
(even a single amino acid substitution) in the leptin receptor was
found to be associated with increased Eh infection susceptibility
(Duggal et al., 2011).
Phagocytosis by E. histolytica
The fate of Eh induced apoptotic host cells (Huston et al.,
2003) and subsequent phagocytosis may play an important role
in the host-parasite relationship in amebiasis. Amebae induced
phagocytosis of erythrocyte is one of the possible distinctive
feature of Eh from the commensal E. dispar (González-Ruiz et al.,
1994). In multicellular organisms, phagocytosis is the last step
of the apoptotic pathway to clear dead cells without provoking
an inflammatory response by the toxic components of dead
cells (Figure 1D; Savill and Fadok, 2000; Fadok et al., 2001).
Similarly, apoptotic host cells are phagocytosed by Eh with the
help of exposed phosphatidylserine (Huston et al., 2003). As Eh
rapidly clears apoptotically killed host cells by phagocytosis, this
limits the spillage of toxic intracellular contents from killed cells.
Through this strategy Eh restrains host inflammatory responses
and build up prolonged infection.
Eh-induced phagocytosis is important for pathogenicity but
very little is known about the amebic receptors and the
corresponding ligands that they bind to. Adherence with host
cells by parasite Gal-lectin is critical for cell death but blocking of
adherence does not prevent phagocytosis (Teixeira et al., 2008).
This suggests the sequential exposure of new ligands on dying
cells as well as the recruitment of new receptors on Eh in addition
to the Gal-lectin following host cell killing (Teixeira et al., 2008).
From an evolutionary concept, Eh phagocytoses bacteria for
nutrient acquisition; therefore amebae preferentially recognize
and phagocytose apoptotic cells that have surface similarities with
bacteria (Teixeira et al., 2008).
Ameba Trogocytosis
Recently, a new mechanism of Eh killing came to light. Using
live cell imaging technology it was discovered that following host
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FIGURE 1 | Immune evasion of E. histolytica (Eh) by host cell killing. (A) Contact between Eh and host cell is mediated by the Gal-lectin and host cell surface
Gal and GalNAc receptors. Other amebic proteins involved in host cell attachment include the trans-membrane serine, threonine, and isoleucine proteins (STIRP) and
transmembrane kinase family member TMKb1-9. After Eh-host contact, three events can take place-(B) amebic trogocytosis (C) apoptotic cell death (D)
phagocytosis. In (B) larger cells undergo amebic trogocytosis. Amebic trogocytosis require PI3K and C2PK signal transduction for actin polymerization. (C) Host cells
that have been induced to undergo apoptosis express phosphatidylserine (PS) and C1q complement protein that induce opsonization by ameba involving amebic
calreticulin receptor. Finally, in (D) both apoptotically death cell and smaller cell undergo phagocytosis. Signal transduction for phagocytosis is also mediated by PI3K
and EhC2PK and influences actin polymerization. PI3K-phosphoinositide 3 kinase, C2PK-C2 domain containing protein kinase, TMK39-Transmembrane kinase family
member.
cell attachment, Eh trophozoites ingest separate parts (bites) of
host cells which was termed “amebic trogocytosis” (Figure 1B;
Ralston et al., 2014). This was a very rapid process as within 1min
of attachment amebic trogocytosis is initiated. Due to biting
off and ingestion of separate pieces of host cells, intracellular
calcium levels were elevated and this triggered ultimate cell
death, evidenced by the loss of cell membrane integrity (Ralston
et al., 2014). Interestingly, when trophozoites were incubated
with either live or pre-killed host cells, only live cells were
seen to be trogocytosed by ameba and pre-killed cells were
ingested whole (phagocytosed; Ralston et al., 2014; Ralston,
2015). The cell surface characteristics of pre-killed host cells
might be different from the directly killed cells and Eh might
use this surface difference to determine the type of ingestion
(Ralston, 2015). After ingestion of bites, amebae detach from
the host cell, and the ingested cell eventually dies. It was
speculated that this process contributes to amebic invasion in
the colon as Eh can also trogocytose mucosal epithelial cells.
Though amebic trogocytosis is a rapid process, this depends on
specific conditions like physiological temperature, amoebic actin
rearrangements, Gal-lectin, EhC2PK (Eh C2-domain-containing
protein kinase), and PI3K (phosphoinositide 3-kinase) signaling
(Ralston et al., 2014). Interference with any of these protein was
shown to reduce Eh trogocytosis and subsequent decrease in host
cell death (Ralston, 2015). It should be noted that trogocytosis
also occurs in multicellular organism and different immune
cell types but this trogocytosis does not trigger cell death. The
exact reason for this distinction is not clear but trogocytosis
in multicellular organisms mainly involves the exchange of cell
membrane fragments; whereas Eh trogocytosis contains target
cell cytoplasm and sometimes organelles (Joly and Hudrisier,
2003; Ralston et al., 2014).
The concept of trogocytosis raises an important question,
whether amebic trogocytosis is different from phagocytosis.
The signaling proteins involved in amebic trogocytosis also
play important roles during Eh phagocytosis but amebic
trogocytosis is predominant in living cells (Ralston, 2015).
Some factors might take part in the distinction of trogocytosis
and phagocytosis like target cell deformability, target cell
viability, target cell size etc. (Ralston, 2015). However, the
specific signaling pathways that define amebic trogocytosis
and phagocytosis in Eh are not identified; the relationship
or differences between these two processes are not well
understood.
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CONCLUSION
Eh is an enteric dwelling protozoan parasite that causes
significant morbidity and mortality in developing countries.
This parasite can develop a harmless colonization in the
colon and for unknown reasons it can become a pathogenic
phenotype. With the pathogenic phenotype, Eh disrupts innate
mucosal barriers and penetrates the underlying lamina propria
where the parasite develops potent cytotoxic activity and
extensive tissue destruction. It is still not clear how or
what factors induce this pathogenic phenotype. Human and
parasite genetics along with environmental factors might
have a role as it has been found that not all children
are equally susceptible to infection. Malnutrition extensively
increases disease susceptibility. Gut microbiome also influence
Eh infection susceptibility. Both host innate and adaptive
immune response take part in the elimination of invasive
Eh. The host immune system builds up a rapid inflammatory
response by the secretion of cytokines/chemokines, recruitment
of immune cells (neutrophils, macrophages), and the activation
of inflammasome to control invasive parasites. This parasite also
develops multiple strategies to subvert host immune responses
and to promote its own survival. Eh induces host cell killing
primarily by apoptosis, which is a non-inflammatory cell death
mechanism. Induction of apoptotic cell death is an active and
stepwise process. After inducing cell death, the parasite also
clears the corpse by phagocytosis to inhibit further inflammatory
responses. Another mechanism is amebic trogocytosis where Eh
bites live cells very rapidly and induces cell death. The proper
characterization of proteins, receptor/ligand interaction involved
in parasite adherence, cell killing, phagocytosis, and amebic
trogocytosis will provide promise of future vaccine candidates.
AUTHOR CONTRIBUTIONS
SB, JQ, and KC wrote and edit the manuscript.
FUNDING
This work was supported by a grant from the Natural Sciences
and Engineering Research Council of Canada (NSERC). SB and
JQ is supported by scholarships from NSERC CREATE.
REFERENCES
Andrä, J., Herbst, R., and Leippe, M. (2003). Amoebapores, archaic effector
peptides of protozoan origin, are discharged into phagosomes and kill bacteria
by permeabilizing their membranes. Dev. Comp. Immunol. 27, 291–304. doi:
10.1016/S0145-305X(02)00106-4
Ankri, S., Padilla-Vaca, F., Stolarsky, T., Koole, L., Katz, U., and Mirelman, D.
(1999). Antisense inhibition of expression of the light subunit (35 kDa) of
the Gal/GalNac lectin complex inhibits Entamoeba histolytica virulence. Mol.
Microbiol. 33, 327–337. doi: 10.1046/j.1365-2958.1999.01476.x
Becker, S. M., Cho, K.-N., Guo, X., Fendig, K., Oosman, M. N., Whitehead, R., et al.
(2010). Epithelial cell apoptosis facilitates Entamoeba histolytica infection in the
gut. Am. J. Pathol. 176, 1316–1322. doi: 10.2353/ajpath.2010.090740
Braga, L. L., Ninomiya, H., McCoy, J. J., Eacker, S., Wiedmer, T., Pham, C.,
et al. (1992). Inhibition of the complement membrane attack complex by the
galactose-specific adhesion of Entamoeba histolytica. J. Clin. Invest. 90, 1131.
doi: 10.1172/JCI115931
Bruchhaus, I., Richter, S., and Tannich, E. (1998). Recombinant expression
and biochemical characterization of an NADPH: flavin oxidoreductase from
Entamoeba histolytica. Biochem. J. 330, 1217–1221. doi: 10.1042/bj3301217
Campos-Rodríguezp, R., and Jarillo-Luna, A. (2005). The pathogenicity of
Entamoeba histolytica is related to the capacity of evading innate immunity.
Parasite Immunol. 27, 1–8. doi: 10.1111/j.1365-3024.2005.00743.x
Chadee, K., Petri, W. A. Jr., Innes, D. J., and Ravdin, J. I. (1987). Rat and human
colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica.
J. Clin. Invest. 80, 1245. doi: 10.1172/JCI113199
Cobo, E. R., He, C., Hirata, K., Hwang, G., Tran, U., Eckmann, L.,
et al. (2012). Entamoeba histolytica induces intestinal cathelicidins but is
resistant to cathelicidin-mediated killing. Infect. Immun. 80, 143–149. doi:
10.1128/IAI.05029-11
Davis, P. H., Zhang, X., Guo, J., Townsend, R. R., and Stanley, S. L. (2006).
Comparative proteomic analysis of two Entamoeba histolytica strains with
different virulence phenotypes identifies peroxiredoxin as an important
component of amoebic virulence. Mol. Microbiol. 61, 1523–1532. doi:
10.1111/j.1365-2958.2006.05344.x
Denis, M., and Chadee, K. (1989). Human neutrophils activated by interferon-
gamma and tumour necrosis factor-alpha kill Entamoeba histolytica
trophozoites in vitro. J. Leukocyte Biol. 46, 270–274.
Dey, I., Keller, K., Belley, A., and Chadee, K. (2003). Identification and
characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica.
Proc. Natl. Acad. Sci. U.S.A. 100, 13561–13566. doi: 10.1073/pnas.18358
63100
Duggal, P., Guo, X., Haque, R., Peterson, K. M., Ricklefs, S., Mondal, D., et al.
(2011). A mutation in the leptin receptor is associated with Entamoeba
histolytica infection in children. J. Clin. Invest. 121, 1191. doi: 10.1172/JCI45294
Elnekave, K., Siman-Tov, R., and Ankri, S. (2003). Consumption of
L-arginine mediated by Entamoeba histolytica L-arginase (EhArg)
inhibits amoebicidal activity and nitric oxide production by activated
macrophages. Parasite Immunol. 25, 597–608. doi: 10.1111/j.0141-9838.2004.
00669.x
Fadok, V. A., Bratton, D. L., and Henson, P. M. (2001). Phagocyte receptors for
apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 108, 957.
doi: 10.1172/JCI200114122
Ghadirian, E., and Denis, M. (1992). Entamoeba histolytica extract and
interferon-gamma activation of macrophage-mediated amoebicidal function.
Immunobiology 185, 1–10. doi: 10.1016/S0171-2985(11)80312-8
González-Ruiz, A., Haque, R., Aguirre, A., Castañón, G., Hall, A., Guhl, F.,
et al. (1994). Value of microscopy in the diagnosis of dysentery associated
with invasive Entamoeba histolytica. J. Clin. Pathol. 47, 236–239. doi:
10.1136/jcp.47.3.236
Guerrant, R. L., Brush, J., Ravdin, J. I., Sullivan, J. A., and Mandell, G. L. (1981).
Interaction between Entamoeba histolytica and human polymorphonuclear
neutrophils. J. Infect. Dis. 143, 83–93. doi: 10.1093/infdis/143.1.83
Guo, X., Houpt, E., and Petri, W. A. (2007). Crosstalk at the initial encounter:
interplay between host defense and ameba survival strategies. Curr. Opin.
Immunol. 19, 376–384. doi: 10.1016/j.coi.2007.07.005
Guo, X., Roberts, M. R., Becker, S. M., Podd, B., Zhang, Y., Chua, S. C.,
et al. (2011). Leptin signaling in intestinal epithelium mediates resistance to
enteric infection by Entamoeba histolytica. Mucosal Immunol. 4, 294–303. doi:
10.1038/mi.2010.76
Haque, R., Ali, I. M., Sack, R. B., Farr, B. M., Ramakrishnan, G., and Petri, W. A.
(2001). Amebiasis and mucosal IgA antibody against the Entamoeba histolytica
adherence lectin in Bangladeshi children. J. Infect. Dis. 183, 1787–1793. doi:
10.1086/320740
Haque, R., Mondal, D., Duggal, P., Kabir, M., Roy, S., Farr, B. M., et al.
(2006). Entamoeba histolytica infection in children and protection from
subsequent amebiasis. Infect. Immun. 74, 904–909. doi: 10.1128/IAI.74.2.904-
909.2006
Haque, R., Mondal, D., Shu, J., Roy, S., Kabir, M., Davis, A. N., et al. (2007).
Correlation of interferon-γ production by peripheral blood mononuclear cells
Frontiers in Microbiology | www.frontiersin.org 6 December 2015 | Volume 6 | Article 1394
Begum et al. E. histolytica Immune Evasion Strategies
with childhood malnutrition and susceptibility to amebiasis. Am. J. Trop. Med.
Hyg. 76, 340–344.
Hellberg, A., Nickel, R., Lotter, H., Tannich, E., and Bruchhaus, I. (2001).
Overexpression of cysteine proteinase 2 in Entamoeba histolytica or Entamoeba
dispar increases amoeba-induced monolayer destruction in vitro but does not
augment amoebic liver abscess formation in gerbils. Cell. Microbiol. 3, 13–20.
doi: 10.1046/j.1462-5822.2001.00086.x
Huston, C. D., Boettner, D. R., Miller-Sims, V., and Petri, W. A. Jr. (2003).
Apoptotic killing and phagocytosis of host cells by the parasite Entamoeba
histolytica. Infect. Immun. 71, 964–972. doi: 10.1128/IAI.71.2.964-972.2003
Huston, C. D., Houpt, E. R., Mann, B. J., Hahn, C. S., and Petri, W. A.
(2000). Caspase 3-dependent killing of host cells by the parasite Entamoeba
histolytica. Cell. Microbiol. 2, 617–625. doi: 10.1046/j.1462-5822.2000.
00085.x
Joly, E., and Hudrisier, D. (2003). What is trogocytosis and what is its purpose?
Nat. Immunol. 4:815. doi: 10.1038/ni0903-815
Kammanadiminti, S. J., Mann, B. J., Dutil, L., and Chadee, K. (2004). Regulation
of Toll-like receptor-2 expression by the Gal-lectin of Entamoeba histolytica.
FASEB J. 18, 155–157. doi: 10.1096/fj.03-0578fje
Kaur, U., Sharma, A., Sharma, M., and Vohra, H. (2004). Distribution of
Entamoeba histolytica Gal/GalNAc lectin−specific antibody response in
an endemic area. Scand. J. Immunol. 60, 524–528. doi: 10.1111/j.0300-
9475.2004.01512.x
Korpe, P. S., Liu, Y., Siddique, A., Kabir, M., Ralston, K., Ma, J. Z., et al. (2013).
Breast milk parasite-specific antibodies and protection from amebiasis and
cryptosporidiosis in Bangladeshi infants: a prospective cohort study. Clin.
Infect. Dis. 56, 988–992. doi: 10.1093/cid/cis1044
Leippe, M., Andra, J., and Müller-Eberhard, H. J. (1994). Cytolytic and
antibacterial activity of synthetic peptides derived from amoebapore, the pore-
forming peptide of Entamoeba histolytica. Proc. Natl. Acad. Sci. U.S.A. 91,
2602–2606. doi: 10.1073/pnas.91.7.2602
Leippe, M., Ebel, S., Schoenberger, O. L., Horstmann, R. D., and Müller-Eberhard,
H. J. (1991). Pore-forming peptide of pathogenic Entamoeba histolytica. Proc.
Natl. Acad. Sci. U.S.A. 88, 7659–7663. doi: 10.1073/pnas.88.17.7659
Li, E., Yang, W. G., Zhang, T., and Stanley, S. L. (1995). Interaction of laminin
with Entamoeba histolytica cysteine proteinases and its effect on amebic
pathogenesis. Infect. Immun. 63, 4150–4153. doi: 10.1016/0169-4758(95)
80056-5
Lidell, M. E., Moncada, D. M., Chadee, K., and Hansson, G. C. (2006). Entamoeba
histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain
and dissolve the protective colonic mucus gel. Proc. Natl. Acad. Sci. U.S.A. 103,
9298–9303. doi: 10.1073/pnas.0600623103
Lin, J. Y., Keller, K., and Chadee, K. (1993). Entamoeba histolytica proteins
modulate the respiratory burst potential by murine macrophages. Immunology
78, 291.
Lin, J.-Y., Seguin, R., Keller, K., and Chadee, K. (1994). Tumor necrosis factor alpha
augments nitric oxide-dependent macrophage cytotoxicity against Entamoeba
histolytica by enhanced expression of the nitric oxide synthase gene. Infect.
Immun. 62, 1534–1541.
MacFarlane, R. C., and Singh, U. (2007). Identification of an Entamoeba histolytica
serine-, threonine-, and isoleucine-rich protein with roles in adhesion and
cytotoxicity. Eukaryotic Cell 6, 2139–2146. doi: 10.1128/EC.00174-07
Mondal, D., Petri, W. A., Sack, R. B., Kirkpatrick, B. D., and Haque, R. (2006).
Entamoeba histolytica-associated diarrheal illness is negatively associated with
the growth of preschool children: evidence from a prospective study. Trans. R.
Soc. Trop. Med. Hyg. 100, 1032–1038. doi: 10.1016/j.trstmh.2005.12.012
Moonah, S. N., Jiang, N. M., and Petri, W. A. Jr. (2013). Host immune
response to intestinal amebiasis. PLoS Pathog. 9:e1003489. doi:
10.1371/journal.ppat.1003489
Mortimer, L., and Chadee, K. (2010). The immunopathogenesis of Entamoeba
histolytica. Exp. Parasitol. 126, 366–380. doi: 10.1016/j.exppara.2010.03.005
Mortimer, L., Moreau, F., Cornick, S., and Chadee, K. (2014). Gal-lectin-dependent
contact activates the inflammasome by invasive Entamoeba histolytica.Mucosal
Immunol. 7, 829–841. doi: 10.1038/mi.2013.100
Mortimer, L., Moreau, F., Cornick, S., and Chadee, K. (2015). The NLRP3
inflammasome is a pathogen sensor for invasive Entamoeba histolytica via
activation of α5β1 integrin at the macrophage-amebae intercellular junction.
PLoS Pathog. 11:e1004887. doi: 10.1371/journal.ppat.1004887
Petri, W. A. (2003). Therapy of intestinal protozoa. Trends Parasitol. 19, 523–526.
doi: 10.1016/j.pt.2003.09.003
Que, X., and Reed, S. L. (1997). The role of extracellular cysteine proteinases in
pathogenesis of Entamoeba histolytica invasion. Parasitol. Today 13, 190–194.
doi: 10.1016/S0169-4758(97)01043-0
Ralston, K. S. (2015). Chew on this: amoebic trogocytosis and host cell
killing by Entamoeba histolytica. Trends Parasitol. 31, 442–452. doi:
10.1016/j.pt.2015.05.003
Ralston, K. S., and Petri, W. A. (2011a). Tissue destruction and
invasion by Entamoeba histolytica. Trends Parasitol. 27, 254–263. doi:
10.1016/j.pt.2011.02.006
Ralston, K. S., and Petri, W. A. (2011b). The ways of a killer: how does
Entamoeba histolytica elicit host cell death? Essays Biochem. 51, 193–210. doi:
10.1042/bse0510193
Ralston, K. S., Solga, M. D., Mackey-Lawrence, N. M., Bhattacharya, A., and Petri,
W. A. Jr. (2014). Trogocytosis by Entamoeba histolytica contributes to cell
killing and tissue invasion. Nature 508, 526–530. doi: 10.1038/nature13242
Ravdin, J. I., and Guerrant, R. L. (1981). Role of adherence in cytopathogenic
mechanisms of Entamoeba histolytica: study with mammalian tissue culture
cells and human erythrocytes. J. Clin. Invest. 68, 1305. doi: 10.1172/JCI110377
Ravdin, J. I., Sperelakis, N., and Guerrant, R. L. (1982). Effect of ion channel
inhibitors on the cytopathogenicity of Entamoeba histolytica. J. Infect. Dis. 146,
335–340. doi: 10.1093/infdis/146.3.335
Reed, S. L., Ember, J. A., Herdman, D. S., DiScipio, R. G., Hugli, T. E., and Gigli,
I. (1995). The extracellular neutral cysteine proteinase of Entamoeba histolytica
degrades anaphylatoxins C3a and C5a. J. Immunol. 155, 266–274.
Rico, G., Leandro, E., Rojas, S., Gimenéz, J. A., and Kretschmer, R. R. (2003).
The monocyte locomotion inhibitory factor produced by Entamoeba histolytica
inhibits induced nitric oxide production in human leukocytes. Parasitol. Res.
90, 264–267. doi: 10.1007/s00436-002-0780-7
Saffer, L. D., and Petri, W. A. (1991). Role of the galactose lectin of Entamoeba
histolytica in adherence-dependent killing of mammalian cells. Infect. Immun.
59, 4681–4683.
Santi-Rocca, J., Weber, C., Guigon, G., Sismeiro, O., Coppee, J. Y., and Guillen,
N. (2008). The lysine and glutamic acid-rich protein KERP1 plays a role in
Entamoeba histolytica liver abscess pathogenesis. Cell. Microbiol. 10, 202–217.
doi: 10.1111/j.1462-5822.2007.01030.x
Savill, J., and Fadok, V. (2000). Corpse clearance defines the meaning of cell death.
Nature 407, 784–788. doi: 10.1038/35037722
Sen, A., Chatterjee, N. S., Akbar, M. A., Nandi, N., and Das, P. (2007). The
29-kilodalton thiol-dependent peroxidase of Entamoeba histolytica is a factor
involved in pathogenesis and survival of the parasite during oxidative stress.
Eukaryotic Cell 6, 664–673. doi: 10.1128/EC.00308-06
Seydel, K. B., Smith, S. J., and Stanley, S. L. (2000). Innate immunity to amebic liver
abscess is dependent on gamma interferon and nitric oxide in a murine model
of disease. Infect. Immun. 68, 400–402. doi: 10.1128/IAI.68.1.400-402.2000
Seydel, K. B., and Stanley, S. L. (1998). Entamoeba histolytica induces host cell death
in amebic liver abscess by a non-Fas-dependent, non-tumor necrosis factor
alpha-dependent pathway of apoptosis. Infect. Immun. 66, 2980–2983.
Shrimal, S., Bhattacharya, S., and Bhattacharya, A. (2010). Serum-dependent
selective expression of EhTMKB1-9, a member of Entamoeba histolytica
B1 family of transmembrane kinases. PLoS Pathog. 6:e1000929. doi:
10.1371/journal.ppat.1000929
Sim, S., Yong, T.-S., Park, S.-J., Im, K.-I., Kong, Y., Ryu, J.-S., et al. (2005). NADPH
oxidase-derived reactive oxygen species-mediated activation of ERK1/2 is
required for apoptosis of human neutrophils induced by Entamoeba histolytica.
J. Immunol. 174, 4279–4288. doi: 10.4049/jimmunol.174.7.4279
Stanley, S. L. (2003). Amoebiasis. Lancet 361, 1025–1034. doi: 10.1016/S0140-
6736(03)12830-9
Teixeira, J. E., Heron, B. T., and Huston, C. D. (2008). C1q-and collectin-
dependent phagocytosis of apoptotic host cells by the intestinal protozoan
Entamoeba histolytica. J. Infect. Dis. 198, 1062–1070. doi: 10.1086/591628
Tillack, M., Biller, L., Irmer, H., Freitas, M., Gomes, M. A., Tannich, E., et al.
(2007). The Entamoeba histolytica genome: primary structure and expression
of proteolytic enzymes. BMC Genomics 8:170. doi: 10.1186/1471-2164-8-170
Tillack, M., Nowak, N., Lotter, H., Bracha, R., Mirelman, D., Tannich, E.,
et al. (2006). Increased expression of the major cysteine proteinases by
stable episomal transfection underlines the important role of EhCP5 for the
Frontiers in Microbiology | www.frontiersin.org 7 December 2015 | Volume 6 | Article 1394
Begum et al. E. histolytica Immune Evasion Strategies
pathogenicity of Entamoeba histolytica. Mol. Biochem. Parasitol. 149, 58–64.
doi: 10.1016/j.molbiopara.2006.04.009
Voigt, H., Olivo, J.-C., Sansonetti, P., and Guillén, N. (1999). Myosin IB from
Entamoeba histolytica is involved in phagocytosis of human erythrocytes. J. Cell
Sci. 112, 1191–1201.
Wang, W., and Chadee, K. (1995). Entamoeba histolytica suppresses gamma
interferon-induced macrophage class II major histocompatibility complex Ia
molecule and IA beta mRNA expression by a prostaglandin E2-dependent
mechanism. Infect. Immun. 63, 1089–1094.
Wang, W., Keller, K., and Chadee, K. (1994). Entamoeba histolytica
modulates the nitric oxide synthase gene and nitric oxide production by
macrophages for cytotoxicity against amoebae and tumour cells. Immunology
83, 601.
Wilson, I. W., Weedall, G. D., and Hall, N. (2012). Host-parasite interactions
in Entamoeba histolytica and Entamoeba dispar: what have we learned from
their genomes? Parasite Immunol. 34, 90–99. doi: 10.1111/j.1365-3024.2011.
01325.x
Yu, Y., and Chadee, K. (1997). Entamoeba histolytica stimulates interleukin
8 from human colonic epithelial cells without parasite-enterocyte contact.
Gastroenterology 112, 1536–1547. doi: 10.1016/S0016-5085(97)70035-0
Zambrano-Villa, S., Rosales-Borjas, D., Carrero, J. C., and Ortiz-Ortiz, L. (2002).
How protozoan parasites evade the immune response. Trends Parasitol. 18,
272–278. doi: 10.1016/S1471-4922(02)02289-4
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Begum, Quach and Chadee. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 8 December 2015 | Volume 6 | Article 1394
